Sanofi Reports P-II Study Results of Frexalimab for the Treatment of Relapsing Multiple Sclerosis
June 1, 2023
PharmaShots Weekly Snapshots (May 08 - 12, 2023)
May 13, 2023
Sanofi Reports P-IIIb Trial (HARMONIE) Results of Nirsevimab for the Prevention of Hospitalizations due to RSV-Related LRTD
May 12, 2023
Sanofi and Regeneron Report P-III Trial (PRIME) and (PRIME2) Results of Dupixent (dupilumab) for the Treatment of Prurigo Nodulari...
May 9, 2023
Sanofi’s Dupixent (dupilumab) Receives Health Canada’s Approval for Adults and Adolescent Patients Aged ≥12 Years with Eosinophili...
May 5, 2023
Top Performing Drug – Dupixent (April Edition)
April 26, 2023
Back to Home
Incisive News in 3 Shots.
First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2023 PharmaShots - All Rights Reserved.